Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.19B Sell
3,377,306
-19,639
-0.6% -$7M 0.32% 55
2025
Q4
$1.11B Buy
3,396,945
+988,856
+41% +$314M 0.3% 70
2025
Q3
$708M Buy
2,408,089
+104,920
+5% +$30.4M 0.23% 81
2025
Q2
$684M Buy
2,303,169
+376,228
+20% +$107M 0.24% 83
2025
Q1
$597M Sell
1,926,941
-675,059
-26% -$199M 0.22% 96
2024
Q4
$687M Sell
2,602,000
-357,220
-12% -$106M 0.24% 89
2024
Q3
$940M Sell
2,959,220
-382,648
-11% -$125M 0.35% 64
2024
Q2
$1.03B Sell
3,341,868
-26,542
-0.8% -$7.8M 0.4% 57
2024
Q1
$885M Buy
3,368,410
+339,536
+11% +$99.4M 0.38% 55
2023
Q4
$931M Buy
3,028,874
+71,709
+2% +$19.5M 0.42% 44
2023
Q3
$840M Buy
2,957,165
+191,485
+7% +$47.8M 0.41% 44
2023
Q2
$622M Buy
2,765,680
+468,653
+20% +$109M 0.31% 75
2023
Q1
$582M Sell
2,297,027
-629,326
-22% -$154M 0.31% 70
2022
Q4
$799M Buy
2,926,353
+468,762
+19% +$126M 0.44% 45
2022
Q3
$575M Buy
2,457,591
+784,987
+47% +$190M 0.34% 58
2022
Q2
$411M Sell
1,672,604
-195,939
-10% -$48M 0.33% 72
2022
Q1
$470M Buy
1,868,543
+101,975
+6% +$23.4M 0.32% 75
2021
Q4
$408M Buy
1,766,568
+385,593
+28% +$81.4M 0.26% 93
2021
Q3
$294M Sell
1,380,975
-269,915
-16% -$62.1M 0.21% 121
2021
Q2
$402M Buy
+1,650,890
New +$406M 0.28% 77

Other funds holding AMGN

Amundi's AMGN Position: Q1 2026 in Review

Amundi reduced its Amgen (AMGN) stake by 0.58% in Q1 2026, selling an estimated $7M and leaving 3,377,306 shares worth $1.19B. The position accounts for 0.32% of the portfolio, ranked #55.

Amundi first reported a position in AMGN in Q2 2021 and has held it in 20 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Amundi held 3,377,306 shares of Amgen worth $1.19B as of Q1 2026.
  • Amundi sold 19,639 Amgen shares in Q1 2026, an estimated $7M.
  • Amgen made up 0.32% of Amundi's portfolio in Q1 2026, its #55 holding.
  • Amundi first reported a position in Amgen in Q2 2021 and has held it in 20 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.